Term [clinicaltrials_vocabulary:Term]
Bio2RDF uri
Paroxetine [clinicaltrials_resource:00016c9c0eeef9ff2a46404d9c77337b]Antineoplastic Agents [clinicaltrials_resource:0004b8f693c96d681b7cb3cf9683c0fd]Ehlers-Danlos Syndrome [clinicaltrials_resource:00072f176862ae5012d717f2858fcf03]Triamcinolone hexacetonide [clinicaltrials_resource:0010ff4bad94a5c0aa92f6004b37cc60]Sodium sulfate [clinicaltrials_resource:00129bd648cb20f1dcd21d20ac83a754]Hemangioma, Cavernous [clinicaltrials_resource:001e3095947b1a9d3b8aa7962265f434]Retinal Perforations [clinicaltrials_resource:00329e725c5c5bd16eb22c23e9e073d9]Corneal Edema [clinicaltrials_resource:0055d73915235cfadf28d47641362210]Acromegaly [clinicaltrials_resource:005e837817c21a0393b99843cbfee450]Familial Hypophosphatemic Rickets [clinicaltrials_resource:006826d8a5a33853dc7d808c29d5eba5]Lung Injury [clinicaltrials_resource:007ee4777eba672a7514b938348289d1]Performance-Enhancing Substances [clinicaltrials_resource:0082ba93d9af6830273e95d7e4b5b223]Arteritis [clinicaltrials_resource:008d1cda49c9230d4a5434ac592c09e3]Digestive System Diseases [clinicaltrials_resource:00984d6536a09daaa5133879282aca25]Prolapse [clinicaltrials_resource:00a0503ba21ed004d80b3eac50b69cb4]Colitis, Ulcerative [clinicaltrials_resource:00ad51be377e52d7f886ac6896200955]Small Cell Lung Carcinoma [clinicaltrials_resource:00d4d384c3a612aee30588f8980ad052]Agammaglobulinemia [clinicaltrials_resource:00d66cd2c739f0df48d9c1b7430b04a1]Fabry Disease [clinicaltrials_resource:00e24aaffd391fffb7d3ca954363cf05]Deflazacort [clinicaltrials_resource:00eae5b8cc762660f7172fc3d3439883]Parecoxib [clinicaltrials_resource:00f4899f93623030373c36b928ce925c]Blood Substitutes [clinicaltrials_resource:00fa70d741047b67d4fe6c8d5ecd4e62]Warfarin [clinicaltrials_resource:00fb95037ac6b3e040933a49bc5cbdfa]Tenosynovitis [clinicaltrials_resource:0102ddbca8e157963b916313e62277fa]Zoledronic acid [clinicaltrials_resource:01099f1466f5f4a468632aa06743475e]Etanidazole [clinicaltrials_resource:010f821a178763cf8e045c90a49c9ba7]Hematuria [clinicaltrials_resource:011ec417310e19ba22f6d3aa89723f52]Hip Fractures [clinicaltrials_resource:012b59d4711b0819614664899a92ccc9]Temocillin [clinicaltrials_resource:012ea270161e898811fd3214390c1de7]Nasopharyngitis [clinicaltrials_resource:0130fc5e267443d5fc2ac2a32f803ae7]Erysipelas [clinicaltrials_resource:0131340b4cb028224fcea4abb1f3865f]WAGR Syndrome [clinicaltrials_resource:01326e9fb31c749ab2178c20455120b1]Keratoderma, Palmoplantar, Diffuse [clinicaltrials_resource:013f5735c022ca33d8206701f05f0cb0]Chorioretinitis [clinicaltrials_resource:01403ef0e3d5057df8519c57b11d0d46]Leukemia, Neutrophilic, Chronic [clinicaltrials_resource:0143cba31645de9f7fa0b80e4c0e8bad]Spondylarthropathies [clinicaltrials_resource:014c61958c9fe8345975078d1f3cc513]Furosemide [clinicaltrials_resource:015b96f02895ccd4fd5798fba0a9330a]Follicular Cyst [clinicaltrials_resource:015c1d6c0a9d7543d6d10de77e5d92e6]Roxithromycin [clinicaltrials_resource:015f8f521c512068a46c3d3ea61535d8]Mestranol [clinicaltrials_resource:0166192da545e6d9717c8a4343ac3a50]
type
Term [clinicaltrials_vocabulary:Term]
Bio2RDF identifier
Bio2RDF namespace
clinicaltrials_vocabulary
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_vocabulary:Term
identifier
clinicaltrials_vocabulary:Term
title
Term
@en
label
Term [clinicaltrials_vocabulary:Term]
@en